Portfolio company
Vortex Biotech
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides circulating tumour cell isolation systems for clinicians, researchers and pharmaceutical companies to support cancer diagnosis and patient monitoring.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vortex
This company produces automated liquid biopsy systems that isolate circulating tumour cells from blood samples for researchers and clinicians in the oncology sector.
Smartcatch
This company develops microtechnology devices for isolating circulating tumour cells from blood samples to assist researchers and clinicians in cancer diagnosis and monitoring.
LiquidCell Dx
This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.
Avant Genomics
The company develops an automated platform for liquid biopsy sample preparation to assist clinical laboratories in cancer detection and monitoring.
Cyclomics
This biotechnology firm develops DNA sequencing and AI-powered diagnostic software for clinicians and researchers to detect cancer and classify tumours using liquid biopsies.
Verinnogen
This company develops handheld 3D surface-profiling devices for measuring subcutaneous tumours to support pre-clinical oncology researchers and drug developers.
Fyr Bio
This company develops liquid biopsy diagnostic tools and biomarkers using extracellular vesicle enrichment technology for healthcare providers and pharmaceutical researchers.
PreComb
This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.
